The expression of bcl-2 in chronic liver diseases

Saudi Medical Journal

Volumn 26, Issue 8, 2005, Pages 1245-1249

  Mutluay, Ruya ^a   Ozenirler, Seren ^a   Poyraz, Aylar ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; FORMALDEHYDE; PARAFFIN; PROTEIN BCL 2; VIRUS DNA; VIRUS RNA;

ADULT; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTHROMBIN TIME; TURKEY (REPUBLIC);

ADULT; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 24744462540     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
2. Desoize B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 1994; 14: 2291-2294.
3. Abe-Dohmae S, Harada N, Yamada K, Tanaka R. Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem Biophys Res Comm 1993; 191: 915-921.
4. Skopelitou A, Hadjiyannakis M, Alexopoulou V, Krikoni O, Kamma S, Agnantis N. Topographical Immunohistochemical Expression of bcl-2 protein in Human Liver Lesions. Anticancer Res 1996; 16: 975-978.
5. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-886.
6. Boise LH, Gottschalk AR, Quintans J. Bcl-2 related proteins in apoptosis regulation. Curr Top Microbiol Immunol 1995; 200: 107-121.
7. Monaghan P, Robertson D, Amos TA, Dyer MJ, Mason DY, Greaves MF. Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 1992; 40: 1819-1825.
8. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365-369.
9. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer ST. Bcl-2 as an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
10. Blandino, G, Strano S. Bcl-2: the Pendulum of the Cell Fate. J. Exp. Clin. Cancer Res 1997; 16: 3-10.
11. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer S. J. Bcl-2 Functions in an Antioxidant Pathway to prevent apoptosis. Cell 1993; 75: 241-251.
12. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on fas antigen-mediated cell death. J Immunol 1993; 151: 621-627.
13. Fiorentino M, D'Errico A, Altimari A, Barozzi C, Grigioni WF. High levels of bcl-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas. Diagn Mol Pathol 1999; 8: 189-194.
14. Emily HY, Beth L, Lawrence HB. Bax-independent inhibition of apoptosis by Bcl-XL. Nature February 1996; 379: 554-556.
15. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-157.
16. Nakamoto Y, Kaneko S, Kabayashi K. Increased susceptibility to apoptosis and attenuated bcl-2 expression in T lymphocytes and monocytes from patients with advanced chronic hepatitis C. J Leukoc Biol 2002; 72: 49-55.
17. Dolcetti R, Boiocchi M. Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol 1996; 14 (Suppl 14): 3-13.
18. Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1993; 85: 439-445.
19. Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M, et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 1996; 12: 1055-1062.
20. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 1993; 7: 563-568.
21. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994;144: 460-465.
22. Tsamandas A, Thomopoulos K, Gogos C, Tepetes K, Kourelis T, Ravazoula P, et al. Expression of bcl-2 oncoprotein in cases of acute and chronic viral hepatitis Type B and Type C. Dig Dis Sci 2002; 47: 1678-1624.
23. Frommel TO, Yong S, Zarling EJ. Immunohistochemical evaluation of bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: A Novel Mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol 1999; 94: 178-182.
24. Zhao M, Zhang N-X, Economou M, Blaha I, Laissue JA, Zimmermann A. Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25: 237-245.
25. Koga H, Sakisara S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25: 1077-1084.
26. Ravazoula P, Tsamandas A, Kardamakis D, Gogos C, Karatza C, Thomopoulos K, et al. The potential role of bcl-2 mRNA and protein expression in hepatocellular carcinomas. Anticancer Res 2002; 22: 1799-1806.
27. Iwata M, Harada K, Kono N, Kaneko S, Kobayashi K, Nakanuma Y. Expression of bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 2000; 31: 179-184.
28. Gonzalez-Peralta RP, Davis GL, Lau JYN. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994; 21:255-259.
29. Knodell RG, Ishak KG, Black WC, Chen TS. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.